Medexus Pharmaceuticals Inc at SNN Network Canada Virtual Event Transcript
Welcome, everyone, to the SNN Network Canada Virtual Event. I'm your host, Robert Kraft. And on behalf of SNN Network, I'd like to introduce our next presenters here at the event. Joining us virtually is Ken d'Entremont, CEO and Marcel Konrad, CFO of Medexus Pharmaceuticals. It's a publicly traded company. I got two symbols for you: MDP on the TSX and MEDXF on the OTCQX.
We're going to do this presentation a little bit differently. We're going to start off with about 10 minutes of presentation and then once that's finished, we'll do a little informal Q&A while I'll pop back on screen here. So with that, I am going to throw it to Ken and Marcel. Guys, take it away.
' -
Thanks, Robert. Thanks for the opportunity to present Medexus here today. Our forward-looking statements can be found on our website, which is at medexus.com. So Medexus is a commercially focused pharmaceutical company with products in the orphan drug, rare disease space. We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
